Polymerisable compounds and the use thereof in liquid-crystal media and liquid-crystal displays

US9776952B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9776952-B2
Application numberUS-201615016885-A
CountryUS
Kind codeB2
Filing dateFeb 5, 2016
Priority dateMar 9, 2010
Publication dateOct 3, 2017
Grant dateOct 3, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays having a polymer-stabilized blue phase, and in LC media for LC displays of the PS or PSA type (“polymer sustained” or “polymer sustained alignment”), and to LC media and LC displays comprising these compounds.

First claim

Opening claim text (preview).

The invention claimed is: 1. Compounds of the formula I P a -(Sp a ) s1 -A 2 -CH 2 CH 2 -A 1 -CH 2 C 2 -A 3 -(Sp b ) s2 -P b   I wherein the individual radicals have the following meaning P a P b each, independently of one another, denote a polymerisable group, Sp a , Sp b on each occurrence, identically or differently, denote a spacer group, s1, s2 each, independently of one another, denote 0 or 1, A 1 , A 2 , A 3 each, independently of one another, denote a radical selected from the following groups a) the group consisting of trans-1,4-cyclohexylene, 1,4-cyclohexenylene and 4,4′-bicyclohexylene, wherein one or more non-adjacent CH 2 groups may be replaced by —O— and/or —S— and wherein, one or more H atoms may be replaced by F, b) the group consisting of 1,4-phenylene and 1,3-phenylene, wherein, one or two CH groups may be replaced by N and wherein, one or more H atoms may be replaced by L, c) the group consisting of tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobut-1,3-diyl, piperidine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl, each of which may, in addition, be mono- or polysubstituted by L, d) the group consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may also be replaced by heteroatoms, preferably selected from the group consisting of bicyclo[1.1.1]pentane-1,3-diyl, bicyclo-[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N, L on each occurrence, identically or differently, F denotes, Cl, CN, SCN, SF 5 or straight-chain or branched, in each case optionally fluorinated alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy having 1 to 12 C atoms, R 0 , R 00 each, independently of one another, denote H, F or straight-chain or branched alkyl having 1 to 12 C atoms, wherein, one or more H atoms may be replaced by F, M denotes —O—, —S—, —CH 2 —, —CHY— or —CY 1 Y 2 —, Y and Y 1 each, independently of one another, have one of the meanings indicated above for R 0 , or denote Cl or CN, and preferably denote H, F, Cl, CN, OCF 3 or CF 3 , and in which one or more of the radicals A 1 , A 2 and A 3 are selected from the group d) consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may also be replaced by heteroatoms, preferably in which one or more of the radicals A 1 , A 2 and A 3 are selected from the group consisting of bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N. 2. Compounds of the formula IA G-O-(Sp a ) s1 -A 2 -CH 2 CH 2 -A 1 -CH 2 CH 2 -A 3 -(Sp b ) s2 -O-G′  IA wherein Sp a , Sp b , A 1 , A 2 , A 3 , s1 and s2 have the following meaning, Sp a , Sp b on each occurrence, identically or differently, denote a spacer group, s1, s2 each, independently of one another, denote 0 or 1, A 1 , A 2 , A 3 each, independently of one another, denote a radical selected from the following groups a) the group consisting of trans-1,4-cyclohexylene, 1,4-cyclohexenylene and 4,4′-bicyclohexylene, wherein, one or more non-adjacent CH 2 groups may be replaced by —O— and/or —S— and wherein, one or more H atoms may be replaced by F, b) the group consisting of 1,4-phenylene and 1,3-phenylene, wherein, one or two CH groups may be replaced by N and wherein, one or more H atoms may be replaced by L, c) the group consisting of tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobut-1,3-diyl, piperidine-1,4-diyl, thiophene-2,5-diyl and selenophene-2,5-diyl, each of which may, in addition, be mono- or polysubstituted by L, d) the group consisting of saturated, partially unsaturated or fully unsaturated, and optionally substituted, polycyclic radicals having 5 to 20 cyclic C atoms, one or more of which may also be replaced by heteroatoms, preferably selected from the group consisting of bicyclo[1.1.1]pentane-1,3-diyl, bicyclo-[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, where, in addition, one or more H atoms in these radicals may be replaced by L, and/or one or more double bonds may be replaced by single bonds, and/or one or more CH groups may be replaced by N, and G and G′ each, independently of one another, denote an H atom or a protecting group. 3. The compounds of formula I of claim 1 wherein, A 1 is selected from a group consisting of: 4. The compounds of formula IA of claim 2 wherein, A 1 is selected from a group consisting of:

Assignees

Inventors

Classifications

  • Five-membered ring with oxygen(s) in fused, bridged or spiro ring systems · CPC title

  • Macromolecular compounds · CPC title

  • Ph-Ph-COO-Ph · CPC title

  • the heterocyclic ring being a six-membered ring · CPC title

  • containing esters · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9776952B2 cover?
The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays having a polymer-stabilized blue phase, and in LC media for LC displays of the PS or PSA type (“polymer sustained” or “polymer sustained alignment”…
Who is the assignee on this patent?
Merk Patent Ges Mit Beschrankter Haftung, Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/0275. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).